baber/WOPTO huggingface dataset:
Patent AT-E140276-T1 (AT)
Inventor: SUH KYUNG W
IPC: D01F6/00
Filed: 1991-08-19
Granted: 1996-07-15
Abstract: Fibrous thermal insulation comprises an intimate blend of A) non-graphitic carbonized fibers having an LOI value greater than 40, a percentage char value greater than 65, and a thermal conductivity less than 1.7 W/(m.<o>K) (1.7 W/m.<o>C)), and B) hollow thermoplastic fibers.
Patent AT-E103025-T1 (AT)
Inventor: SCHEUCHZER ANTOINE PASCAL
IPC: E01B29/17
Filed: 1991-07-05
Granted: 1994-04-15
Abstract: The new rails (R2) to be laid are continuously heated so they can be neutralised. To this end, they are lifted up and exposed to a heat source in the form of two heating tunnels (15) which are mounted on a vehicle (1) which moves continuously along the old rails (R1). Each heating tunnel (15) has passed through it a length of new rail (R2). At the same time, the old rails (R1) are detached from the sleepers and, after the passage of the said vehicle (1), are deposited alongside the track, or are removed. The new rails, which are brought to and maintained at the neutralisation temperature, are laid continuously onto the sleepers so as to be fastened thereto. 
<IMAGE>
Patent AT-E98881-T1 (AT)
Inventor: OLIVE PETER
IPC: A61M37/00
Filed: 1991-03-27
Granted: 1994-01-15
Abstract: An implantable valve accumulator pump for the delivery of medication is disclosed. The implantable pump comprises a drug reservoir maintained at constant pressure vapor. The medication metering assembly comprises a fixed volume accumulator positioned between a pair of valves. The valves alternately open and close to admit medication from the reservoir into the accumulator and to dispense a precise volume spike to an outlet catheter. In order to minimize dead volume and insure complete discharge, the accumulator employs a titanium diaphragm seated in one position by a recessed stop and in the discharge position by a spacer plate having a concentric groove pattern. The grooves are in fluid communication with the inlet and outlet. Also, a wide groove extending between inlet and outlet provides fluid communication between the grooves. The unit is externally programmed.
Patent AT-E116043-T1 (AT)
Inventor: WEBER GUENTER
IPC: F16K1/34
Filed: 1991-10-17
Granted: 1995-01-15
Abstract: PCT No. PCT/AT91/00112 Sec. 371 Date Apr. 15, 1993 Sec. 102(e) Date Apr. 15, 1993 PCT Filed Oct. 17, 1991 PCT Pub. No. WO92/07208 PCT Pub. Date Apr. 30, 1992High pressure valve having a valve cone (12) guided by a valve spindle (10) within a valve housing (1, 2), the sealing surface (13) of the valve cone engaging, in the closed position, an annular ridge (15) of hard metal constituting a valve seat, whereby the sealing surface (13) at least of the valve cone (12) is made of a soft metal, preferrably aluminum.
Patent AT-E121753-T1 (AT)
Inventor: KERI GYOERGY DR
IPC: A61K38/04
Filed: 1992-01-27
Granted: 1995-05-15
Abstract: A subject matter of the invention are octapeptide or heptapeptide amide derivatives of formula <CHEM>  wherein   X1   stands for an aromatic D-amino acid rest; or a D-phenylglycyl, p-hydroxyphenylglycyl, o-aminobenzoyl, m-aminobenzoyl, D-tetrahydroisoquinolylcarbonyl or sarcosylalanyl; or a <CHEM>  group,  in which latter A1   means the rest of an amine  or means an amino group  or means an alkoxy, aryloxy or aralkyloxy group; X2   represents an aromatic amino acid rest or a histidyl group; X3   means a D-tryptophyl, o-aminobenzoyl, m-aminobenzoyl, aspartyl, D-aspartyl,  beta -aspartyl,  beta -D-aspartyl or aminosuccinyl group; or a group indicated for X1; X4   stands for an amino acid rest bearing an alkyl or aralkyl side chain; or a prolyl or  beta -alanyl group; or a valence bond; X5   means an aromatic amino acid rest or a threonyl group; R1   represents hydrogen or a <CHEM>  group,  in which latter A2   means hydrogen or an alkyl group; R2   means hydrogen, -S- or a -S-acetamidomethyl, phenyl or p-hydroxyphenyl group; R3   stands for hydrogen or hydroxyl; R4   means a phenyl or p-hydroxyphenyl group; or -S-or a -S-acetamidomethyl group when the meaning of R2 is the same group; or a methyl group when R3 is hydroxyl and n   is 1, 2, 3 or 4 and acid addition salts thereof. o
Patent AT-E142169-T1 (AT)
Inventor: GLEMZA RIMANTAS
IPC: B01J27/16
Filed: 1992-05-08
Granted: 1996-09-15
Abstract: Aluminum phosphate compositions are provided which are characterized simultaneously by high porosity and phosphorous-to-aluminum ratios of approximately 1.0. The high porosity of these compositions is a function of high pore volume coupled with low surface area, resulting in high average pore diameter. These materials have excellent properties as catalysts and catalyst supports. Methods of making the compositions are also provided.
Patent AT-E153968-T1 (AT)
Inventor: TRENTO BRUNO
IPC: B65G1/14
Filed: 1992-09-18
Granted: 1997-06-15
Abstract: The packets (2) arranged in the storage racks in a substantially vertical orientation are extracted using an apparatus formed by a carriage (3) fitted with a withdrawal platform (10), by virtue of which the support (4) of the packet in which a withdrawal is to be made is moved; this packet is thus placed horizontally with an operation performed by the jack (12), whilst the metal sheets or other stored products are raised using jacks (18, 19), in order to ensure easy withdrawal. <IMAGE>
Patent AT-E163646-T1 (AT)
Inventor: DUGGAN MARK E
IPC: A61K31/19
Filed: 1992-05-07
Granted: 1998-03-15
Abstract: Fibrinogen receptor antagonists of the formula: <CHEM> are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
Patent AT-E142022-T1 (AT)
Inventor: TERAO TOSHIHIKO
IPC: A61K49/00
Filed: 1992-06-18
Granted: 1996-09-15
Abstract: The total quantity of elastase in a specimen containg human granulocyte elastase in the form of a mixture of free elastase with an elastase-inhibitor complex or complexes is precisely detected by adding an inhibitor to convert the free elastase into an elastase-inhibitor complex. The elastase present can then be measured by immunoassay as the total amount including the previously-existing elastase-inhibitor complex. It is thus possible to measure precisely the total amount of elastase in mucus collected from the cervical canal of a pregnant woman, sputum or a rinsed solution of bronchovesicular lavage in which free elastase is mixed with an elastase-inhibitor complex. It is also possible to predict and prevent threatened premature delivery, premature delivery or premature rupture of membranes by immunoassay of mucus collected from the cervical canal of a pregnant woman; to make a diagnosis of chronic or repetitive airway infections and pulmonary emphysema based on chronic respiratory diseases by immunoassay of sputum and a rinsed solution of bronchovesicular lavage; and to make a diagnosis of urinary tract infections by immunoassay of urine.
Patent AT-E150954-T1 (AT)
Inventor: KAMBIN PARVIZ
IPC: A61B17/28
Filed: 1992-07-23
Granted: 1997-04-15
Abstract: There is disclosed a forceps having forceps jaws (3) operated by manually operable handle (4a,4b) and also having a cable (8) connected between the forceps jaws (3) and a manually operable actuator (7) such that the forceps jaws (3) are swung to a desired position when the actuator (7) is operated. <IMAGE>   <IMAGE>
Patent AT-E141843-T1 (AT)
Inventor: SHOWALTER MICHAEL S
IPC: B23K7/06
Filed: 1992-11-27
Granted: 1996-09-15
Abstract: A thermochemical scarfing method and apparatus are disclosed which allows a greater diagonal standoff distance from the metal workpiece during preheating. The method includes preheating the end of the metal workpiece, and then scarfing the workpiece by directing a scarfing oxygen stream onto the workpiece at an acute angle and while moving the workpiece past the oxygen outlet port. The preheating step includes generating a high speed stream of oxidizing gas and a concentric stream of fuel gas coaxially about the central stream, so that the momentum of the central stream is maintained. As a result, the effective flame heating distance may be extended, and the manifold and head assembly which supports the preheating gas nozzles may be moved back from the workpiece a significant standoff distance so as to avoid damage from dislodged molten metal slag.
Patent AT-E171749-T1 (AT)
Inventor: NITECKI JEAN
IPC: E03D1/14
Filed: 1992-07-16
Granted: 1998-10-15
Abstract: The invention relates to a flushing device allowing the delivery, at the user's choice, of different, predetermined quantities of water. In this device, the draining of the water from the tank (1) is effected by a single valve (25, 26), the movable head (25) of which is integral with a support (21). The operating member (9) includes several elements (11, 12) acting on the same control rod (13) so as to cause the translation of the movable valve head (25). The support (21) is fitted with retaining means (32, 33) arranged opposite mutually independent blocking systems (34, 35). The presence of water generates on one and/or the other of the blocking systems (34, 35) a thrust which tends to bring about the cooperation of at least one blocking system (34, 35) with the retaining means (32, 33) associated therewith, in order to maintain the valve (25) in the open position. <IMAGE>
Patent AT-E143069-T1 (AT)
Inventor: BESANA RAFFAELE
IPC: B32B5/02
Filed: 1992-04-01
Granted: 1996-10-15
Abstract: The following describes elasticized artificial leather characterized in that it is formed by a woven support material comprising warp threads and weft threads, said material being coated on at least one of its two sides by at least one layer of synthetic polymer, said woven material having its weft made from elasticized yarn produced using elastomeric fibers. A further object of the present invention is a process for production of the elasticized artificial leather. <IMAGE>
Patent AT-E133098-T1 (AT)
Inventor: AGUSTIN PAYA JOSE
IPC: B23B27/14
Filed: 1992-05-14
Granted: 1996-02-15
Abstract: PCT No. PCT/DE92/00410 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed May 14, 1992 PCT Pub. No. WO92/21467 PCT Pub. Date Dec. 10, 1992.Cutting inserts are provided at their rake faces with a plurality of raised chip-forming elements in the form of longitudinal ribs which can be notched to have longitudinally-separated segments and at least some of which are parallel to one another.
Patent AT-E153794-T1 (AT)
Inventor: KOZIOL STEPHAN
IPC: B65D21/02
Filed: 1992-08-17
Granted: 1997-06-15
Abstract: A mounting receptacle for records and cassettes has at least two elements which are arranged near one another and provided with receiving devices for records and cassettes to be inserted, a first wall and a second wall provided in each of the elements and parts for connecting the elements securely and detachably in the region of the first wall and the second wall. The connecting parts include at least one bayonet screw having a screw neck with one end provided with a head and another end provided with a cam-like bayonet shoulder, and overlapping bore holes provided in the second wall and the first wall of the elements so that the bayonet screw can be inserted in the overlapping bore holes of the second wall and the first wall of the elements and being flush with surfaces of the second wall and the first wall on insides of the elements without projecting out. The bore hole in the second wall on the inside of the elements reaches a thickness of the screw head and has a diameter corresponding to a diameter of the screw head and also tapers in a portion of the second wall to a maximum diameter of the screw neck including the bayonet shoulder. The bore hole in the first wall on the inside of the elements has a diameter of the screw neck of the bayonet screw including the bayonet shoulders, the connecting member also including cam-like projections which project into the bore hole in the region directed toward the outside of the elements, the bayonet shoulders of the bayonet screw engaging under the cam-like projections.
Patent AT-E145025-T1 (AT)
Inventor: BACKLUND AKE
IPC: D21C1/00
Filed: 1992-08-11
Granted: 1996-11-15
Abstract: A process for the continuous digestion of cellulosic fiber material, comprising impregnation with impregnating liquid consisting of at least one fresh digesting liquor, in a closed impregnating system and subsequent digestion with digesting liquid in a closed digester system, said impregnating liquid being supplied through a supply system, together with steamed fibre material, to an inlet end of the impregnating system, liquid being withdrawn from the impregnating system at a point (46) located at a predetermined distance from said inlet end. According to the invention such a first quantity of liquid (F) is withdrawn at said withdrawal point (46) and recirculated directly to the supply system that a predetermined minimum ratio between liquid and fibre material is continuously maintained in the impregnating system prior to said withdrawal point (46), the liquid in said liquid to fibre material ratio being derived from original moisture (A) in the fibre material, condensates (B, C) from an initial steaming of the fibre material, and added fresh digesting liquor(s) (D and/or E) besides said withdrawn and recirculated quantity of liquid (F).
Patent AT-E144248-T1 (AT)
Inventor: WEICHERT ANDREAS DR
IPC: A61K31/155
Filed: 1993-06-25
Granted: 1996-11-15
Abstract: Benzoylguanidines of the formula I <IMAGE>  with   R(1) equal to R(4)-SOm or R(5)R(6)N-SO2- with R(4) and R(5) equal to alk(en)yl, -CnH2n-R(7), and with R(7) equal to cycloalkyl or phenyl, where R(5) can also mean H, R(6) equals H or C1-C4-alkyl,   R(2) is hydrogen, (cyclo)alk(en)(yn)yl, aryl and hetaryl   R(3) is defined as R(2),  and their pharmaceutically tolerated salts, are described. Compounds I are obtained by reacting compounds of the formula II <IMAGE> with guanidine, in which L is a leaving group which can easily undergo nuclophilic substitution. Compounds I are outstandingly suitable as antiarrhythmic drugs with cardioprotective component for the treatment and prophylaxis of infarct and for treating angina pectoris, and they also greatly reduce preventively the pathophysiological processes in the development of ischaemia-induced damage. Furthermore, I are distinguished by a potent inhibitory action on cell proliferation. They can thus be used as antiatherosclerotics, remedies for the late complications of diabetes, cancers, fibrotic disorders such as pulmonary, hepatic or renal fibrosis. They are effective inhibitors of the cellular sodium-proton antiporter (Na<+>/H<+> exchanger).
Patent AT-E146797-T1 (AT)
Inventor: ZUCCHINI UMBERTO
IPC: C08F4/68
Filed: 1993-08-05
Granted: 1997-01-15
Abstract: Catalysts component of the (co)polymerization of alpha-olefins CH2=CHR, wherein R is hydrogen or an alkyl radical having from 1 to 8 carbon atoms, comprising a product of the composition:    VCly . z(b> wherein (b) represents an organic compound selected from alkyl, aryl and acyl halides, y is a number higher than 2 and lower than 4, and preferably comprised between 2.5 and 3.5 and z is a number higher than zero and lower than or equal to 2, and preferably between 0.002 and 1. Components can be obtained as products of the reaction, carried out at temperatures higher than 10 DEG C, between VCl4 and the compound (b). Particularly preferred among compounds (b) are benzoyl chloride, p-methoxybenzoyl chloride and p-chloro benzoyl chloride. From the components of the invention, either supported or not, catalysts having high activity particularly useful for the production of ethylene polymers showing broad molecular weight distribution can be prepared.
Patent AT-E158810-T1 (AT)
Inventor: FLOSBACH CARMEN DR
IPC: C09D133/10
Filed: 1993-11-03
Granted: 1997-10-15
Abstract: A binder composition is described which leads to acid-resistant coatings. The binder composition comprises:   A) 10-90% by weight of one or more crosslinking compounds having on average at least two groups capable of transesterification, B) 90-10% by weight of one or more (meth)acrylic copolymers, polyesters and/or polyurethane resins having at least one alpha,beta-unsaturated group attached via the carbonyl carbon atom of   <IMAGE> and with a C=C equivalent weight of 85-1800 and a number-average molecular mass (Mn) of 170-10,000 g/mol, and an OH number of 20-200 mg of KOH/g, the percentages by weight of components A and B being based in each case on the solids content and adding up to give 100% by weight, and C) 0.1-10% by weight of one or more initiators which can be activated thermally and/or photochemically, D1) 0-20% by weight of one or more melamine resin crosslinking agents,   D2) 0-40% by weight of one or more blocked polyisocyanates, E) 0-40% by weight of one or more (meth)acryloyl-functionalised reactive diluents, and F) 0-30% by weight of one or more diols, triols, polyols and/or hydroxy-functional polyethers, polyesters and/or (meth)acrylic copolymers, and optionally solvents, conventional paint additives, optionally water, optionally pigments and optionally fillers, the percentages by weight of components C), D), E) and F) being based in each case on the solids content and on the sum of the percentages by weight of components A) and B).
Patent AT-E178333-T1 (AT)
Inventor: FRASER DAVID
IPC: C07D213/38
Filed: 1993-12-06
Granted: 1999-04-15
Abstract: Complex of general formula I <IMAGE> in which R1, R2 and R3, which may be identical or different, represent separately a linear or branched alkyl radical of 1 to 5 carbon atoms, or, together with the nitrogen atom to which they are attached, a heterocyclic radical having 5 to 7 carbon atoms; "alk" represents a linear or branched alkylene radical having 1 to 5 carbon atoms; R4 to R8, which may be identical or different, represent hydrogen, a hydroxyl, alkoxy or aryloxy group, a primary, secondary or tertiary amino group, or the group -alk-N<+)<R1R2R3) in which "alk", R1, R2 and R 3 have the above meanings; M represents a transition metal such as Fe, Ru or Os; X represents an anion and n represents an integer corresponding to the number of positive charges of the complex.
Patent AT-E146799-T1 (AT)
Inventor: VAN ZON ARIE
IPC: C08G67/00
Filed: 1993-02-15
Granted: 1997-01-15
Abstract: The invention provides a polyolefin-derived copolymer obtainable by a process which comprises reacting:   (i) a mixture of (a) a polyolefin or succinic anhydride derivative thereof, and (b) a polyamine having terminal -NH2 groups, or   (ii) the reaction product of (a) and (b); with carbon monoxide, hydrogen and a diene; in the presence of a suitable solvent and a catalyst system comprising a source of cationic rhodium; optionally a source of cationic ruthenium; an aromatic N-heterocyclic ligand; and a source of an anion other than a halide; a process for preparing the copolymer; and lubricating oil and fuel compositions containing the copolymer.
Patent AT-E158658-T1 (AT)
Inventor: JONES BARBARA LYNN
IPC: G01T1/02
Filed: 1993-03-12
Granted: 1997-10-15
Abstract: A method of monitoring nuclear radiation comprises providing a diamond radiation sensor element (10) having a nitrogen impurity concentration of less than 150 ppm. The sensor element is subjected to nuclear radiation, while being stimulated with light of a selected wavelength or range of wavelengths, preferably in the ultraviolet or near- ultraviolet range, resulting in light emissions from the sensor element. Typically, the sensor element is fixed to the end of an optical fibre (12), the far end (14, 16) of the fibre being used to channel stimulating light to the sensor element and to feed resultant light emissions from the sensor element to a photomultiplier tube (20). The invention includes apparatus for carrying out the method. <IMAGE>
Patent AT-E184198-T1 (AT)
Inventor: BIRRENBACH GERD
IPC: A61K9/20
Filed: 1993-05-11
Granted: 1999-09-15
Abstract: To combat disorders in which Helicobacter pylori is involved, a combination product which is composed of amoxycillin and bismuth and which displays significantly better efficacy than treatment with a bismuth salt alone has been developed. It is possible by a suitable combination of the ancillary substances to produce a stable, small, hard tablet which can be swallowed as a whole and which contains as auxiliaries preferably polyvinylpyrrolidone, microcrystalline cellulose, sodium carboxymethylcellulose, magnesium stearate and colloidal silica.
Patent AT-E139334-T1 (AT)
Inventor: MENZER WOLFGANG
IPC: G01B7/00
Filed: 1993-03-15
Granted: 1996-06-15
Abstract: A method for determining an extension of an object with an extensometer, and an extensometer for performing the method, include two legs being movable in a spreading plane and each having one end connected to a joint and another end connected to the object, with the extension spreading the legs apart. The spreading plane is oriented approximately parallel to a surface of the object between the other ends of the legs. Foot-plates, each being carried by a respective one of the legs, being oriented in the spreading plane and having a region projecting beyond the other ends of the legs, are fastened to the object at the region.
Patent AT-E198768-T1 (AT)
Inventor: TROWERN ANGUS R
IPC: C12N15/09
Filed: 1993-05-07
Granted: 2001-02-15
Abstract: Synthetic molecules are provided comprising one or more immunoglobulin binding domains as well as sequences which have at least 90% homology to these domains.
Patent AT-E207064-T1 (AT)
Inventor: CASTRO PINEIRO JOSE LUIS
IPC: A61K31/55
Filed: 1993-07-28
Granted: 2001-11-15
Abstract: PCT No. PCT/GB93/01599 Sec. 371 Date Jan. 26, 1995 Sec. 102(e) Date Jan. 26, 1995 PCT Filed Jul. 28, 1993 PCT Pub. No. WO94/03437 PCT Pub. Date Feb. 17, 1994Compounds of Formula (I), and salts and prodrugs thereof, wherein R1 represents H, optionally substituted C1-6alkyl or C3-7cycloalkyl; R2 is NHR12 or (CH2)sR13 where 5 is 0, 1 or 2; R3 represents C1-6alkyl, halo or NR6R7; R4 and R5 are H, C1-12alkyl optionally substituted by NR9R9' or an azacyclic or azabicyclic group, optionally substituted C4-9cycloalkyl, C4-9cycloalkyl C1-4alkyl, aryl, arylC1-6alkyl or azacyclic or azabicyclic groups, or R4 and R5 together form the residue of an optionally substituted azacyclic or azabicyclic ring system; x is 0, 1, 2 or 3; R12 is optionally substituted phenyl or pyridyl; R13 represents a group (A) wherein R14 is H or C1-6alkyl; R15 is H, C1-6alkyl, halo or NR6R7; and the dotted line is an optional covalent bond; are CCK and/or gastrin antagonists useful in therapy.    <IMAGE>  (I)   <IMAGE>  (A)
Patent AT-E149389-T1 (AT)
Inventor: GRAF RALPH
IPC: B21K1/14
Filed: 1994-04-14
Granted: 1997-03-15
Abstract: The method is used to produce profile wire by profile-pressing of the starting wire, in particular for the production of all-steel fittings. In order in a particularly simple manner to avoid the curvature of the wire which occurs with the conventional method, production is accomplished by the following steps:   a) setting together and joining of at least two starting wires along areas extending essentially in the longitudinal direction of the wires, b) profile pressing of the joined starting wires while maintaining constant the ratios of the cross-sectional areas to one another perpendicular to the longitudinal direction of the starting wires. At least two starting wires expediently consist of different materials.   <IMAGE>